Several studies suggest that combination therapy of an anti-TNF with an immunomodulator (thiopurine or methotrexate (MTX)) has a superior effect over anti-TNF monotherapy in IBD [110,111] (Table 4). The gene discussed is TNF; the disease is inflammatory bowel disease.